Recently published papers: renal support in acute kidney injury - is low dose the new high dose?
Despite 21st century definitions, the management of acute kidney injury remains steadfastly rooted in the 20th century with treatment being principally supportive. Protection from potential causative agents is an essential part of management and to that end protection against contrast-induced nephropathy has received yet more attention. When optimization of volume status, haemodynamic parameters, electrolyte and acid-base disturbances have failed we turn to renal replacement therapy. The time 'bought' on renal support gives a period for renal recovery but although renal replacement therapy is widely employed, many management issues remain unanswered, including the timing, duration and the dose of treatment. In contrast to respiratory support for acute lung injury, for example, there is a paucity of large randomized studies addressing these fundamental issues. We describe some recent studies focusing on these issues with the hope that they may lead to better treatment for our patients.
Syed
Yadullah
Y
Worthing General Hospital, Worthing, West Sussex BN11 2DH, UK.
Tomlinson
James A P
JA
Forni
Lui G
LG
D000136:Acid-Base Equilibrium; D000208:Acute Disease; D058186:Acute Kidney Injury / Q000517:prevention & control / Q000628:therapy*; D015331:Cohort Studies; D003287:Contrast Media / Q000009:adverse effects; D004231:Diuresis; D006801:Humans; D007668:Kidney / Q000293:injuries*; D007674:Kidney Diseases / Q000139:chemically induced / Q000453:epidemiology; D012044:Regression Analysis; D017582:Renal Replacement Therapy / Q000379:methods*; D016896:Treatment Outcome
D003287:Contrast Media